Synthesis of organometallic ruthenium(II) complexes with strong activity against several human cancer cell lines

J Inorg Biochem. 2012 Sep:114:65-74. doi: 10.1016/j.jinorgbio.2012.04.014. Epub 2012 May 2.

Abstract

A new family of "RuCp" (Cp=η(5)-C(5)H(5)) derivatives with bidentate N,O and N,N'-heteroaromatic ligands revealed outstanding cytotoxic properties against several human cell lines namely, A2780, A2780CisR, HT29, MCF7, MDAMB231, and PC3. IC(50) values were much lower than those found for cisplatin. Crystal structure of compound 4 was determined by X-ray diffraction studies. Density functional theory (DFT) calculations performed for compound 1 showed electronic flow from the ruthenium center to the coordinated bidentate ligand, in agreement with the electrochemical studies and the existence of a metal-to-ligand charge-transfer (MLCT) band evidenced by spectroscopic data.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cisplatin / pharmacology
  • Crystallography, X-Ray
  • Electrochemical Techniques
  • Humans
  • Inhibitory Concentration 50
  • Ligands
  • Magnetic Resonance Spectroscopy
  • Models, Molecular
  • Organometallic Compounds / chemical synthesis*
  • Organometallic Compounds / pharmacology
  • Quantum Theory
  • Ruthenium / chemistry*
  • Static Electricity

Substances

  • Antineoplastic Agents
  • Ligands
  • Organometallic Compounds
  • Ruthenium
  • Cisplatin